ARTICLE | Clinical News
Toujeo insulin glargine regulatory update
April 13, 2015 7:00 AM UTC
EMA’s CHMP recommended approval of Toujeo insulin glargine to treat adult Type I and II diabetics. Toujeo is a 300 units/mL formulation of insulin glargine, a synthetic sustained-release subcutaneous ...